NCBI_Build	Hugo_Symbol	Variant_Classification	Tumor_Sample_Barcode	HGVSp_Short	HGVSp	HGVSg	Chromosome	Start_Position	End_Position	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	GENE_IN_ONCOKB	VARIANT_IN_ONCOKB	MUTATION_EFFECT	ONCOGENIC	LEVEL_1	LEVEL_2	LEVEL_3A	LEVEL_3B	LEVEL_4	LEVEL_R1	LEVEL_R2	LEVEL_R3	HIGHEST_LEVEL	CITATIONS	LEVEL_Dx1	LEVEL_Dx2	LEVEL_Dx3	HIGHEST_DX_LEVEL	LEVEL_Px1	LEVEL_Px2	LEVEL_Px3	HIGHEST_PX_LEVEL
GRCh37	CUL1	Missense_Mutation	TCGA-A6-2672-01A-01W-0833-10	p.Y466S	Tyr466Ser								False	False	Unknown																			
GRCh37	AKT3	Nonsense_Mutation	TCGA-05-4417-01	p.E182*	Glu182*								True	False	Unknown																			
GRCh37	PIK3CA	Missense_Mutation	TCGA-02-0033-01	p.E542K	Glu542Lys	3:g.178936082G>A	3	178936082	178936082	G	A	A	True	True	Gain-of-function	Oncogenic										30206110;20593314;16432179;26627007;17376864;30093452;31996845								
GRCh37	FGFR3	Missense_Mutation	TCGA-05-4417-01	p.V271M	Val271Met								True	False	Unknown																			
GRCh37	EGFR	Missense_Mutation	TCGA-06-0155-01	p.H304Y	His304Tyr	7:g.55223543C>T	7	55223543	55223543	C	T	T	True	True	Likely Gain-of-function	Likely Oncogenic										29533785								
GRCh37	PTEN	Missense_Mutation	TCGA-06-0155-01	p.C136R	Cys136Arg	10:g.89692922T>C	10	89692922	89692922	T	C	C	True	True	Loss-of-function	Likely Oncogenic					GSK2636771,AZD8186				LEVEL_4	29663862;23475934;28645941;Hansen et al. Abstract# 2570, ASCO 2017(http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2570)								
GRCh37	FGFR2	Missense_Mutation	TCGA-02-0033-01	p.Q212K	Gln121Lys								True	False	Unknown																			
GRCh37	ATM	Missense_Mutation	TCGA-05-4417-01	p.L2890R	Leu2890Arg								True	True	Likely Loss-of-function	Likely Oncogenic				Olaparib					LEVEL_3B	23585524;32343890								
GRCh37	KRAS	Missense_Mutation	TCGA-05-4417-01	p.G12C	Gly12Cys	12:g.25398285C>A	12	25398285	25398285	C	A	A	True	True	Gain-of-function	Oncogenic			AMG-510		Trametinib,Cobimetinib,Binimetinib				LEVEL_3A	28572459;16051643;25705018;32792368;26841430;24256730;Fakih et al. Abstract# 3003, ASCO 2019(https://meetinglibrary.asco.org/record/172411/abstract);31666701;32955176;Govindan et al. Abstract# ESMO 2019(https://oncologypro.esmo.org/Meeting-Resources/ESMO-2019-Congress/Phase-1-Study-of-AMG-510-a-Novel-Molecule-Targeting-KRAS-G12C-Mutant-Solid-Tumors);25435214;23200175;24746704;28783719;29247021;Bhagwat et al. Abstract# 4973, AACR 2017(http://cancerres.aacrjournals.org/content/77/13_Supplement/4973);Robarge et al. Abstract# DDT02-03, AACR 2014(http://cancerres.aacrjournals.org/content/74/19_Supplement/DDT02-03);Burrows et al. Abstract# 5168, AACR 2017(http://cancerres.aacrjournals.org/content/77/13_Supplement/5168)								
GRCh37	KRAS	Missense_Mutation	TCGA-05-4417-01	p.G12C	Gly12Cys	12:g.25398285_25398286delinsAG	12	25398285	25398286	CA	AG	AG	True	True	Gain-of-function	Oncogenic			AMG-510		Trametinib,Cobimetinib,Binimetinib				LEVEL_3A	28572459;16051643;25705018;32792368;26841430;24256730;Fakih et al. Abstract# 3003, ASCO 2019(https://meetinglibrary.asco.org/record/172411/abstract);31666701;32955176;Govindan et al. Abstract# ESMO 2019(https://oncologypro.esmo.org/Meeting-Resources/ESMO-2019-Congress/Phase-1-Study-of-AMG-510-a-Novel-Molecule-Targeting-KRAS-G12C-Mutant-Solid-Tumors);25435214;23200175;24746704;28783719;29247021;Bhagwat et al. Abstract# 4973, AACR 2017(http://cancerres.aacrjournals.org/content/77/13_Supplement/4973);Robarge et al. Abstract# DDT02-03, AACR 2014(http://cancerres.aacrjournals.org/content/74/19_Supplement/DDT02-03);Burrows et al. Abstract# 5168, AACR 2017(http://cancerres.aacrjournals.org/content/77/13_Supplement/5168)								
GRCh37	RB1	Nonsense_Mutation	TCGA-02-0033-01	p.Q702*	Gln702*								True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
GRCh37	TP53	Missense_Mutation	TCGA-02-0033-01	p.R248Q	Arg248Gln	17:g.7577538C>T	17	7577538	7577538	C	T	T	True	True	Likely Loss-of-function	Likely Oncogenic										24814347;16778209;21445056								
GRCh37	NF1	Splice_Site	TCGA-02-0033-01	p.X1445_splice	X1445_splice	17:g.29586049G>A	17	29586049	29586049	G	A	A	True	False	Likely Loss-of-function	Likely Oncogenic										31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187								
GRCh37	STK11	Missense_Mutation	TCGA-05-4417-01	p.H168R	His168Arg								True	False	Unknown																			
GRCh37	TERT	5'Flank	TCGA-05-4417-01			5:g.1295228G>A	5	1295228	1295228	G	A	A	True	True	Gain-of-function	Oncogenic										24657534;25048572;23530248;23348506;23348503;23887589								
GRCh37	MYD88	Missense_Mutation	TCGA-05-4417-01	M232T									True	True	Gain-of-function	Oncogenic										25359991								
